trending Market Intelligence /marketintelligence/en/news-insights/trending/Y1WxeQ7IuUDjDVeXEnlkww2 content esgSubNav
In This List

Matinas BioPharma raises $12.7M in warrant tender offer

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Matinas BioPharma raises $12.7M in warrant tender offer

Matinas BioPharma Holdings Inc. raised $12.7 million after warrant holders exchanged their holdings for company shares.

A total of 30,966,350 warrants, or 84.31% of all warrants outstanding, were exercised under the company's tender offer.

Proceeds raised will help the company up-list itself to a national securities exchange while advancing its lead anti-infective product candidates MAT2203 and MAT2501 beyond key clinical data readouts during 2017.

SternAegis Ventures acted as the warrant solicitation agent.

Matinas BioPharma is listed on the OTCQB.